We are live on ! Find out more
IRD

Opus Genetics
IRD

27 hedge funds and large institutions have $2.58M invested in Opus Genetics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

4% more funds holding

Funds holding: 26 → 27 (+1)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

1% less capital invested

Capital invested by funds: $2.62M → $2.58M (-$32.9K)

Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
4
Closed
5
Calls
$64K
Puts
–
Net Calls
+$64K
Net Calls Change
+$49K

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$155K
2
Citadel Advisors
Citadel Advisors
Florida
+$30.6K
3
Jane Street
Jane Street
New York
+$24.3K
4
BlackRock
BlackRock
New York
+$21.2K
5
Northern Trust
Northern Trust
Illinois
+$9.84K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$26K
2
UBS Group
UBS Group
Switzerland
-$8.79K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$8.17K
4
Group One Trading
Group One Trading
Illinois
-$7.12K
5
Bank of America
Bank of America
North Carolina
-$1.32K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.56M +$1.58K +18 +0.1%
BlackRock
2
BlackRock
New York
$266K +$21.2K +241 +7%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$205K – – –
VF
4
Virtu Financial
New York
$119K +$155K +1,766 New
Northern Trust
5
Northern Trust
Illinois
$116K +$9.84K +112 +7%
BCM
6
Bridgeway Capital Management
Texas
$75K – – –
Zurich Cantonal Bank
7
Zurich Cantonal Bank
Switzerland
$49K – – –
WS
8
Wedbush Securities
California
$36K – – –
HVIA
9
Hudson Valley Investment Advisors
New York
$28K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$24K +$30.6K +348 New
NFC
11
Northeast Financial Consultants
Connecticut
$21K – – –
BMC
12
Benin Management Corp
Connecticut
$20K – – –
Jane Street
13
Jane Street
New York
$19K +$24.3K +276 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$17K -$8.17K -93 -27%
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
$7K – – –
NWM
16
Northwest Wealth Management
Iowa
$6K – – –
UBS Group
17
UBS Group
Switzerland
$4K -$8.79K -100 -66%
Morgan Stanley
18
Morgan Stanley
New York
$2K -$176 -2 -6%
CAGAS
19
Capital Advisory Group Advisory Services
Minnesota
$1K -$1.23K -14 -42%
LTFS
20
Ladenburg Thalmann Financial Services
Florida
$1K – – –
VCM
21
Vigilant Capital Management
Maine
$1K – – –
Wells Fargo
22
Wells Fargo
California
$1K – – –
APA
23
American Portfolios Advisors
New York
$141 +$176 +2 New
FDCDDQ
24
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1 – – –
Renaissance Technologies
25
Renaissance Technologies
New York
– -$26K -364 Closed
1
2

IRD Hedge Fund Activity: Q2 2018 in Review

27 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2018, worth a combined $2.58M — down 1.3% from $2.62M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IRD positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $155K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $26K sold.

  • 27 institutional investors held Opus Genetics (IRD) as of Q2 2018, up from 26 in Q1 2018.
  • Funds reported $2.58M of Opus Genetics stock for Q2 2018, down 1.3% quarter-over-quarter.
  • 6 funds opened new Opus Genetics positions in Q2 2018 and 5 closed out, a net change of +1 holder.
  • The largest Opus Genetics buyer in Q2 2018 was Virtu Financial, an estimated $155K added.
  • The largest Opus Genetics seller in Q2 2018 was Renaissance Technologies, an estimated $26K sold.

Based on aggregated 13F filings for Q2 2018.